Latest news with #IQOS
Business Wire
a day ago
- Business
- Business Wire
Philip Morris International Participates in dbAccess Global Consumer Conference
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE: PM) Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2025 dbAccess Global Consumer Conference in Paris. The event will be webcast live in listen-only mode, beginning at approximately 11:15 a.m. CEST (5:15 a.m. EST), at and on the PMI Investor Relations Mobile Application ( An archived copy of the webcast will be available for approximately one year. 2025 Full-Year Forecast PMI reaffirms its 2025 full-year reported diluted EPS forecast, announced on April 23, 2025, of $7.01 to $7.14. Excluding a total 2025 adjustment of $0.35 per share and a favorable currency impact, at then-prevailing exchange rates, of $0.10 per share, this forecast represents a projected currency-neutral increase of 10.5% to 12.5% versus adjusted diluted EPS of $6.57 in 2024, as outlined in the below table. The assumptions underlying this forecast remain unchanged versus those communicated by PMI in its earnings release of April 23, 2025. Factors described in the Forward-Looking and Cautionary Statements section of this release represent continuing risks to these projections. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. As of December 31, 2024, PMI's smoke-free products were available for sale in 95 markets, and PMI estimates they were used by 38.6 million adults around the world. The smoke-free business accounted for 42% of PMI's first-quarter 2025 total net revenues. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to 'PMI', 'we', 'our' and 'us' mean Philip Morris International Inc., and its subsidiaries. For more information, please visit and Forward-Looking and Cautionary Statements This press release contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; business plans and strategies; and dividends. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI. PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco and/or nicotine use and intellectual property; intense competition; the effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; the impact of natural disasters and pandemics on PMI's business; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; recent and potential future tariffs imposed by the U.S. and other countries; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; if it is unable to attract and retain the best global talent, including women or diverse candidates; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free products performance. PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2024, and the Quarterly Report on Form 10-Q for the first quarter ended March 31, 2025. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that it may make from time to time, except in the normal course of its public disclosure obligations.
The Guardian
3 days ago
- Business
- The Guardian
Tory peer proposed delay on heated tobacco ban after Philip Morris visit
A Conservative peer proposed delaying the UK's proposed ban on heated tobacco, weeks after a leading cigarette company paid for him to visit its research facility in Switzerland. The tobacco and vapes bill would gradually raise the age at which consumers can buy cigarettes and other tobacco products, making the UK the first major economy to chart a course towards phasing out tobacco altogether. But the timetable for heated tobacco could be disrupted after Lord Vaizey put forward an amendment that would require more research to be done into the 'potential' harms that such products can cause relative to cigarettes. Vaizey's proposal came six weeks after he was a guest of Philip Morris International (PMI), whose IQOS product is the world-leading heated tobacco brand, during a two-day visit to its research facility in Neuchâtel, Switzerland. PMI paid for Vaizey's flights and accommodation, according to his own parliamentary disclosures, analysed by the Guardian and the Examination, a non-profit newsroom that investigates global health threats. The cost of the trip was not revealed and neither Vaizey nor PMI said whether other British parliamentarians were there. Three weeks after the trip, on 23 April, Vaizey took part in a House of Lords debate on the tobacco and vapes bill. During the debate, he disclosed his visit to the Philip Morris facility, known as The Cube, where the tobacco company has also hosted politicians from Finland and Colombia. Vaizey said he had met scientists there who were researching heated tobacco. 'There is an argument which says that people should be able to access nicotine if it can be done in a safe way,' said Vaizey, who said he used IQOS products. 'I want to say something controversial: a lot of the tone of this debate looks backward at the sins of the big tobacco. It does not perhaps acknowledge – though that might be too kind a word – that big tobacco has perhaps moved forward in terms of heated tobacco.' On 14 May, six weeks after his visit to Switzerland, Vaizey tabled his amendment, which would delay the ban on heated tobacco products, including the IQOS. He proposed that the health secretary be required to 'assess the harm to human health associated with the use of tobacco related devices' and compare any harms with those caused by cigarettes. The amendment appears to reheat elements of a legal challenge brought by Philip Morris in 2023 against the tobacco and vapes bill, which was initially proposed by the previous government. PMI's challenge questioned whether the government's consultation was 'meaningful', on the basis that the outcome was pre-determined. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion It also sought to limit the scope of the ban to leave out heated tobacco products, which use devices to heat tobacco at a lower temperature than conventional cigarettes. PMI withdrew its challenge after a response from government lawyers, who stated that the relative harms of cigarettes versus heated tobacco were not relevant. This is because the gradual implementation of the ban, which raises the minimum age for tobacco purchase by one year every year, means that nobody affected would ever have been able to choose between the two methods of nicotine ingestion anyway. At the time, Whitehall sources said the legal challenge was a delaying tactic by Philip Morris, whose IQOS heated tobacco product ships around 140m units a year and has replaced Marlboro as its most successful product by net revenue. Martin McKee, professor of European public health at the London School of Hygiene & Tropical Medicine, said Vaizey was repeating the tobacco industry's playbook by suggesting that heated tobacco should be compared with cigarettes 'rather than with the more appropriate comparator of not smoking'. PMI did not respond to questions from the Guardian about Vaizey's trip to Switzerland and its relationship with the Tory peer. Lord Vaizey declined to comment.
Kuwait Times
7 days ago
- Business
- Kuwait Times
PMI's report details progress towards its smoke-free vision
DUBAI: Philip Morris International Inc recently published its sixth annual Integrated Report, marking the company's 10th year of business transformation and sustainability disclosures. The document details PMI's continued progress in delivering long-term value to shareholders and other stakeholders while advancing its purpose of having its smoke-free alternatives make cigarettes obsolete as soon as possible. 'Our 2024 Integrated Report celebrates a milestone year that marked the 10th anniversary of the commercialization of IQOS, VEEV and ZYN and our journey toward achieving one of the most ambitious business transformations in modern history,' said Jacek Olczak, Chief Executive Officer of PMI. 'By the end of 2024, our efforts to expand access to smoke-free products allowed us to reach 95 markets with an estimated 38.6 million adult users, demonstrating our deep commitment to sustainability and business transformation. These achievements fill me with profound optimism as we continue to create long-term value while addressing our product and operational impacts, not only sustaining but accelerating our momentum, accomplishing a number of goals that only a few years ago seemed too ambitious.' The Integrated Report describes the company's strategy, business model, and both product-related ('what' the Company produces) and operational-related ('how' the Company operates) performance. The report explains the Company's performance and approach to sustainability in the context of a comprehensive five-pillar framework that includes compliance and risk mitigation as well as operational efficiency, innovation, and purposeful impact. It emphasizes how regulatory compliance serves as the foundation while risk management ensures business resilience. It highlights how this approach streamlines processes for enhanced productivity and profitability, aligns sustainability with long-term business goals to drive innovation and competitive value, and ultimately aims to lead a significant industry transformation by influencing standards, shaping policy, and driving systemic change that redefines market expectations. 'The path to transformation is rarely linear, and our experience in 2024 reinforces a crucial truth: Achieving a smoke-free future requires collective effort beyond our direct control. Our smoke-free business accounted for approximately 39 percent of PMI's total net revenues for the full year 2024, with an acceleration in top- and bottom-line growth. Competing in the cigarette market while simultaneously working to transform it is not a contradiction but a necessary phase in our journey,' said Emmanuel Babeau, Chief Financial Officer of PMI. 'Our integrated approach—linking financial success with positive impact—positions us well to continue investing in the future. We remain confident that our financial strength, combined with our sustainability leadership, is the right path forward.' Product and Operational Impact: Performance Highlights * Six markets where more than 75% of net revenues are generated from smoke-free. * Over $14 billion cumulative investment behind smoke-free products since 2008 (2023: $12.5) * 99% of total shipment volume covered by youth access prevention programs in indirect retail channels (2023: 98%) * 99% of contracted farmers supplying tobacco to PMI who make a living income (2023: 96%) * 10 human rights impact assessments completed since 2018 in highest-risk countries (2023: 8) * 61% of PMI manufacturing facilities certified as carbon neutral (2023: 43%) * First pre-certified environmental product declarations (EPD) published on IQOS ILUMA i series of devices 'We understand the importance of setting ambitious yet realistic targets that drive our business success. Our Sustainability Index has proven instrumental in ensuring our ambitions are balanced and our metrics are objective, while our enhanced nonfinancial data governance helps us report with precision and consistency,' said Jennifer Motles, Chief Sustainability Officer of PMI. 'Our commitment to sustainability is inseparable from future-proofing our business, creating tangible impacts within our control and sphere of influence, and contributing to a transformation that extends beyond our company.' The Integrated Report 2024 has been prepared with reference to the Global Reporting Initiative (GRI) Universal Standards (2021) and relevant topic-specific standards. The report takes into account guidance from the International Sustainability Standards Board (ISSB) of the IFRS Foundation, including using its SASB Standards, Integrated Thinking Principles, and Integrated Reporting Framework. PMI's SASB Index and GRI Index, which also maps the principles and standards of the UN Global Compact (UNGC), is available on The report is accompanied by the PMI Sustainability KPI Protocol 2024, which provides a transparent explanation of how we define and measure progress for each Sustainability Index KPI. Please visit to learn more and read the full Integrated Report 2024, as well as case studies and market stories and the Sustainability KPI Protocol 2024.
Yahoo
27-05-2025
- Business
- Yahoo
Philip Morris International to Host Webcast of Presentation at the 2025 dbAccess Global Consumer Conference
STAMFORD, CT, May 27, 2025--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live webcast of the company's remarks and Q&A session with Emmanuel Babeau, Chief Financial Officer, at the 2025 dbAccess Global Consumer Conference on Tuesday, June 3, 2025, at approximately 11:15 a.m. CET (5:15 a.m. ET). The Webcast and presentation slides will be available at with a post-event recording of the webcast available for one year at the same site. The webcast will provide a live stream of the entire PMI session and can also be accessed on mobile devices by downloading PMI's free Investor Relations Mobile App at Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. As of December 31, 2024, PMI's smoke-free products were available for sale in 95 markets, and PMI estimates they were used by 38.6 million adults around the world. The smoke-free business accounted for 42% of PMI's first-quarter 2025 total net revenues. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to "PMI", "we", "our" and "us" mean Philip Morris International Inc., and its subsidiaries. For more information, please visit and View source version on Contacts Philip Morris International Investor Relations:Stamford, CT: +1 (203) 904 2410Lausanne: +41 (0)58 242 4666Email: InvestorRelations@ Media: David FraserLausanne: +41 (0)58 242 4500Email: Sign in to access your portfolio
Business Wire
27-05-2025
- Business
- Business Wire
Philip Morris International to Host Webcast of Presentation at the 2025 dbAccess Global Consumer Conference
STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live webcast of the company's remarks and Q&A session with Emmanuel Babeau, Chief Financial Officer, at the 2025 dbAccess Global Consumer Conference on Tuesday, June 3, 2025, at approximately 11:15 a.m. CET (5:15 a.m. ET). The Webcast and presentation slides will be available at with a post-event recording of the webcast available for one year at the same site. The webcast will provide a live stream of the entire PMI session and can also be accessed on mobile devices by downloading PMI's free Investor Relations Mobile App at Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. As of December 31, 2024, PMI's smoke-free products were available for sale in 95 markets, and PMI estimates they were used by 38.6 million adults around the world. The smoke-free business accounted for 42% of PMI's first-quarter 2025 total net revenues. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to 'PMI', 'we', 'our' and 'us' mean Philip Morris International Inc., and its subsidiaries. For more information, please visit and
